# Design Therapeutics, Inc.: Form 8-K, filed Nov 9, 2021

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: 8-K
- Filed: 2021-11-09
- Accepted by EDGAR: Nov 9, 2021, 16:11 ET
- Period: 2021-11-09
- Accession: 0000950170-21-003747
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000095017021003747/dsgn-20211109.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000095017021003747/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000095017021003747/dsgn-20211109.htm

Filed Nov 9, 2021.
Source: SEC EDGAR, the filing index for accession 0000950170-21-003747. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
